Elena Moro: Dear Prof. Vincent, you have recently been awarded with the WFN Medal for Scientific Achievement in Neurology. We congratulate with you for this well-deserved outstanding recognition! In light of your longstanding experience in the world of neuro-immunology in particular, what do you think is it the most recent important discovery in your field? Angela Vincent (AV): Well first of all thank you for the congratulations.  I am thrilled to receive the WFN Medal and it is much appreciated. Neuroimmunology is a relatively recent discipline – probably only first defined in the 1980s. 

The Republic of Lithuania is a state in northern-eastern Europe occupying 65.300 km2 area with Vilnius city as capital and a population of 2.979.000 inhabitants. Neighbors of Lithuania are Latvia, Belarus, Poland, and Russia. It is a parliamentary democracy, with… Continue Reading

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!

by Elena Moro For March 2018, we have selected: Honig LS, Vellas B, Woodward M, et al. Trial of solanezumab for mild dementia due to Alzheimer’s disease. N Engl J Med 2018;378:321-330. Alzheimer’s disease (AD) pathology can be related to either excessive production or reduced elimination of beta amyloid (Aβ), which eventually results in oligomers, fibrils, and neuritic Aβ plaques.

Prof. Corino de Andrade graduated at Lisbon Medical School, Hospital of St Martha, in 1929. He began his practice at the main hospital in Lisbon (Hospital S. José) and kept visiting his Alma Mater with a serious commitment to practice neurology at the department of Egas Moniz, the only one in Portugal. This passion was soon rewarded with the residency in neurology.

Antonio Federico (AF): On January 29-30, there has been in Tubingen the Kick-Off Meeting of the EU Project Solve-RD. You and Prof. Olaf Riess are coordinating this project. Can you summarize the aim and the activities of this important project? Holm Graessner (HG): To obtain a molecularly confirmed diagnosis remains one of the largest challenges for rare disease patients. To jointly tackle this challenge a core group of four European Reference Networks including the European Reference Network for Rare Neurological Diseases has motivated, designed and put together the Solve-RD project which is the first ERN based H2020 funded research project. Solve-RD brings together 21 partners from 10 countries which will be running from 2018 to 2022.

It is our great pleasure to announce the 2nd edition of the EAN Task Force for Rare Neurologic Diseases Teaching Course, to be organized in Cluj-Napoca (Romania), from 5-7 September 2018. As last year’s event was a success, the Task… Continue Reading

We have the sad duty to communicate the death of Professor Eberhard Deisenhammer, a pioneer in neurology and a long-term secretary general and treasurer of the European Federation of Neurologic Societies.

In just a few months the EAN congress in Lisbon will take place, and we invite you all to visit the congress website and browse through the scientific programme with more than 90 sessions to choose from. Find the overview… Continue Reading

  The objective of the “Clinical Fellowship Programme” is to provide a well-defined clinical observational experience in a department with recognised expertise in a specific field.
With this programme, neurologists that are still in the process of training, or recently… Continue Reading

A “National Action Plan 2025” was launched recently by the Danish government, with broad support from most political parties, and a funding of € 63 mill. for 2017-2019.

Dear Prof. Cras, I congratulate you for your election as Chair of the UEMS Section of Neurology. David B. Vodušek (DBV):  It is felt that many European neurologists may not be fully aware of the role of UEMS in general, and the distinctions between SN UEMS and EAN, would you offer your explanation to the readers of the EAN Pages? Patrick Cras (PC): Union Européenne des Médecins Spécialistes, also called European Union of Medical Specialists (UEMS), was founded in 1958, shortly after the founding of the European Common Market.  Those of us who feel inspired by the European project will agree that professional standard setting and continuing professional development has an international dimension.